simvastatin has been researched along with Schizophrenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahn, S; Begemann, MJH; Bruggeman, R; de Witte, LD; Drexhage, H; Gangadin, SS; Grootens, KP; Kahn, RS; Koops, S; Martens, P; Sommer, IE; van Baal, C; van Beveren, N; van Haren, NEM; Veerman, SRT; Veling, W; Wiersma, S | 1 |
| Belmonte-de-Abreu, PS; Ceresér, KM; Cordova, VHS; Dias da Rosa, E; Francesconi, LP; Jacobus, RVM; Oliveira, L; Salah, IA; Victorino, AT | 1 |
| Chaudhry, IB; Deakin, B; Drake, R; Dunn, G; Hallak, J; Hamirani, MM; Husain, MO; Husain, N; Kazmi, A; Kiran, T; Mehmood, N; Rahman, Ru; Stirling, J | 1 |
| Abbasi, N; Akhondzadeh, S; Moazen-Zadeh, E; Rezaei, F; Salehi, B; Shariat, SV; Tajik-Esmaeeli, S | 1 |
| Lightfoot, JD; Mahmud, W; Shekhar, A; Webber, MA | 1 |
3 trial(s) available for simvastatin and Schizophrenia
| Article | Year |
|---|---|
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial.
Topics: Adolescent; Adult; Cognition; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Schizophrenia; Simvastatin; Treatment Outcome; Young Adult | 2021 |
Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial.
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Brazil; Checklist; Clinical Protocols; Cognition; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neuropsychological Tests; Ondansetron; Pakistan; Psychiatric Status Rating Scales; Research Design; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Simvastatin; Time Factors; Treatment Outcome | 2013 |
Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Simvastatin | 2017 |
2 other study(ies) available for simvastatin and Schizophrenia
| Article | Year |
|---|---|
Proinflammatory and anti-inflammatory biomarkers in schizophrenia and influence of simvastatin on the interleukin-6.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Female; Humans; Inflammation; Interleukin-10; Interleukin-12; Interleukin-6; Male; Middle Aged; Schizophrenia; Simvastatin; Tumor Necrosis Factor-alpha | 2019 |
Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin.
Topics: Acute Disease; Adult; Antipsychotic Agents; Compartment Syndromes; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Rhabdomyolysis; Risperidone; Schizophrenia; Simvastatin | 2004 |